Professionals at biotechnology firm Genzyme are discussing funding a medical trial for any latest version of the medical device known as Synvisc. The trial is costly and also the likelihood of success aren't high, however the upside is substantial. The case presents a typical business question: invest or otherwise? The case forces students to wrestle with numerous complex issues and evaluate the financials of the choices.
1. Executive Summary
2. Analysis of the current situation
3. Key Issues
5. Marketing Strategies
6. Action Plan
7. Expected Results
8. Control Mechanisms and Outlook